相似文献
1
Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K.
J Med Virol. 2021 Sep;93(9):5638-5643. doi: 10.1002/jmv.27062. Epub 2021 May 15.
2
Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
Infect Genet Evol. 2022 Jan;97:105164. doi: 10.1016/j.meegid.2021.105164. Epub 2021 Nov 27.
3
Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.
Arch Virol. 2021 Nov;166(11):3173-3177. doi: 10.1007/s00705-021-05208-6. Epub 2021 Aug 27.
4
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
5
Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
J Chin Med Assoc. 2020 Aug;83(8):725-732. doi: 10.1097/JCMA.0000000000000387.
6
Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach.
J Infect Public Health. 2023 Oct;16(10):1544-1555. doi: 10.1016/j.jiph.2023.07.011. Epub 2023 Jul 24.
7
Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations.
Infect Genet Evol. 2022 Jan;97:105153. doi: 10.1016/j.meegid.2021.105153. Epub 2021 Nov 18.
8
Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.
PLoS Pathog. 2021 Jun 7;17(6):e1009619. doi: 10.1371/journal.ppat.1009619. eCollection 2021 Jun.
9
Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021.
Virology. 2022 Jan 2;565:29-37. doi: 10.1016/j.virol.2021.10.005. Epub 2021 Oct 22.
10
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021.
Microbiol Spectr. 2021 Dec 22;9(3):e0109621. doi: 10.1128/Spectrum.01096-21. Epub 2021 Nov 17.
引用本文的文献
1
Structural impact of synonymous mutations in six SARS-CoV-2 Variants of Concern.
PLoS One. 2025 Jul 1;20(7):e0325858. doi: 10.1371/journal.pone.0325858. eCollection 2025.
2
Comparison of the pathogenicity of multiple SARS-CoV-2 variants in mouse models.
Animal Model Exp Med. 2025 Jul;8(7):1302-1312. doi: 10.1002/ame2.70029. Epub 2025 May 20.
3
Broadly potent spike-specific human monoclonal antibodies inhibit SARS-CoV-2 Omicron sub-lineages.
Commun Biol. 2024 Oct 2;7(1):1239. doi: 10.1038/s42003-024-06951-7.
4
COVID-19 mutations: An overview.
World J Methodol. 2024 Sep 20;14(3):89761. doi: 10.5662/wjm.v14.i3.89761.
5
Detection and Characterisation of SARS-CoV-2 in Eastern Province of Zambia: A Retrospective Genomic Surveillance Study.
Int J Mol Sci. 2024 Jun 7;25(12):6338. doi: 10.3390/ijms25126338.
6
Most accurate mutations in SARS-CoV-2 genomes identified in Uzbek patients show novel amino acid changes.
Front Med (Lausanne). 2024 May 31;11:1401655. doi: 10.3389/fmed.2024.1401655. eCollection 2024.
7
Biophysical principles predict fitness of SARS-CoV-2 variants.
Proc Natl Acad Sci U S A. 2024 Jun 4;121(23):e2314518121. doi: 10.1073/pnas.2314518121. Epub 2024 May 31.
8
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies.
Heliyon. 2024 Apr 25;10(9):e30208. doi: 10.1016/j.heliyon.2024.e30208. eCollection 2024 May 15.
9
Current molecular diagnostics assays for SARS-CoV-2 and emerging variants.
Methods Microbiol. 2022;50:83-121. doi: 10.1016/bs.mim.2021.10.003. Epub 2021 Dec 9.
10
Within-host evolution of SARS-CoV-2: how often are mutations transmitted from symptomatic infections?
Virus Evol. 2024 Feb 21;10(1):veae006. doi: 10.1093/ve/veae006. eCollection 2024.
本文引用的文献
1
E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies.
J Mol Graph Model. 2021 Dec;109:108035. doi: 10.1016/j.jmgm.2021.108035. Epub 2021 Sep 17.
2
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.
Immunity. 2021 Aug 10;54(8):1853-1868.e7. doi: 10.1016/j.immuni.2021.07.008. Epub 2021 Jul 30.
3
Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data.
J Cell Physiol. 2021 Oct;236(10):7045-7057. doi: 10.1002/jcp.30367. Epub 2021 Mar 23.
4
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med. 2021 May 20;384(20):1885-1898. doi: 10.1056/NEJMoa2102214. Epub 2021 Mar 16.
5
Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Biochem Biophys Res Commun. 2021 Jan 29;538:97-103. doi: 10.1016/j.bbrc.2021.01.035. Epub 2021 Feb 15.
6
Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex.
J Biomol Struct Dyn. 2022 Sep;40(14):6545-6555. doi: 10.1080/07391102.2021.1886175. Epub 2021 Feb 13.
7
SARS-CoV-2 variants and ending the COVID-19 pandemic.
Lancet. 2021 Mar 13;397(10278):952-954. doi: 10.1016/S0140-6736(21)00370-6. Epub 2021 Feb 11.
8
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.
Nat Med. 2021 Apr;27(4):620-621. doi: 10.1038/s41591-021-01270-4. Epub 2021 Feb 8.
9
SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.
Nat Commun. 2021 Feb 8;12(1):848. doi: 10.1038/s41467-021-21118-2.
10
Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021.
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):95-99. doi: 10.15585/mmwr.mm7003e2.
Zotero 插件